FACULTY CHAIR
Kimber Simmons, MD, MS
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
CU Anschutz Medical Campus
Aurora, CO
Featuring the Silva family
Margot, April, and Jose
Fort Collins, CO
PROGRAM DESCRIPTION
This program is designed to provide a unique patient/family perspective on screening for and living with T1D. It uses an innovative video format to help improve clinician understanding of the disease and its impact on patients and their families.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pediatric endocrinologists, adult endocrinologists, pediatricians, primary care providers (PCPs), and endocrine nurses.
LEARNING OBJECTIVES
- Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
- Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 CPEU.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Kimber Simmons, MD | Discloses that she has received consulting fees and provided contracted research for Provention Bio, a Sanofi company. |
| Margot Silva | Has nothing to disclose |
| April Silva | Has nothing to disclose |
| Jose Silva | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Michael Milano, MD, discloses royalties from Wolters Kluwer.
- Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Senior Program Manager for Med Learning Group has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group has nothing to disclose.
- Marcella Guarino, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: August 19, 2024
EXPIRATION DATE: August 19, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY CHAIR
Kimber Simmons, MD, MS
Associate Professor of Pediatrics
Barbara Davis Center for Diabetes
CU Anschutz Medical Campus
Aurora, CO
Featuring the Belz family:
Anna, Ellie, Kimberly, and Logan
Lafayette, CO
PROGRAM DESCRIPTION
This program is designed to provide a unique patient/family perspective on screening for and living with T1D. It uses an innovative video format to help improve clinician understanding of the disease and its impact on patients and their families.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pediatric endocrinologists, adult endocrinologists, pediatricians, primary care providers (PCPs), and endocrine nurses.
LEARNING OBJECTIVES
- Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
- Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 CPEU.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Kimber Simmons, MD | Discloses that she has received consulting fees and provided contracted research for Provention Bio, a Sanofi company. |
| Anna & Ellie Belz | Have nothing to disclose |
| Kimberly Belz | Has nothing to disclose |
| Logan Belz | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Michael Milano, MD, discloses royalties from Wolters Kluwer.
- Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Senior Program Manager for Med Learning Group has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group has nothing to disclose.
- Marcella Guarino, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: August 27, 2024
EXPIRATION DATE: August 27, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY CHAIR
Peter A. Gottlieb, MD
Professor of Pediatrics and Medicine
Barbara Davis Center, University of Colorado School of Medicine
Aurora, CO
Featuring
Cole Harding
Denver, CO
PROGRAM DESCRIPTION
This program is designed to provide a unique patient/family perspective on screening for and living with T1D. It uses an innovative video format to help improve clinician understanding of the disease and its impact on patients and their families.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pediatric endocrinologists, adult endocrinologists, pediatricians, primary care providers (PCPs), and endocrine nurses.
LEARNING OBJECTIVES
- Describe the clinical presentation of T1D in adults compared to children
- Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
- Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hour.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 CPEU.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Peter A. Gottlieb, MD | Has nothing to disclose |
| Cole Harding | Has nothing to disclose |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Michael Milano, MD, discloses royalties from Wolters Kluwer.
- Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Deb Gordon, Medical Director for Med Learning Group, has nothing to disclose.
- Marissa Mays-Verman, Senior Program Manager for Med Learning Group has nothing to disclose.
- Alexis Klinger, Associate Program Manager for Med Learning Group has nothing to disclose.
- Marcella Guarino, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at [email protected]
RELEASED DATE: September 03, 2024
EXPIRATION DATE: September 03, 2025
Copyright © 2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
